225 related articles for article (PubMed ID: 1378673)
1. [Clinical importance of organ-specific antibodies in ulcerative colitis and Crohn disease].
Goischke EM; Zilly W
Z Gastroenterol; 1992 May; 30(5):319-24. PubMed ID: 1378673
[TBL] [Abstract][Full Text] [Related]
2. [Autoantibodies against the exocrine pancreas and against intestinal goblet cells in the diagnosis of Crohn's disease and ulcerative colitis].
Stöcker W; Otte M; Ulrich S; Normann D; Stöcker K; Jantschek G
Dtsch Med Wochenschr; 1984 Dec; 109(51-52):1963-9. PubMed ID: 6150841
[TBL] [Abstract][Full Text] [Related]
3. [Organ-specific antibodies in children with idiopathic inflammatory bowel disease and their use in clinical practice].
Sýkora J; Varvarovská J; Stozický F; Haschová M; Hanzlíková J
Cas Lek Cesk; 2000 Nov; 139(23):735-7. PubMed ID: 11191745
[TBL] [Abstract][Full Text] [Related]
4. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease?
Castellino F; Rosina F; Bansi DS; Bauducci M; Touscoz GA; Giorda L; Borghesio E; Bessone MP; Astegiano M; Musso A
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):859-64. PubMed ID: 8574718
[TBL] [Abstract][Full Text] [Related]
5. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
Kossa K; Coulthart A; Ives CT; Pusey CD; Hodgson HJ
Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):783-9. PubMed ID: 7496870
[TBL] [Abstract][Full Text] [Related]
6. Antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseases.
Colombel JF; Reumaux D; Duthilleul P; Noël LH; Gower-Rousseau C; Paris JC; Cortot A
Gastroenterol Clin Biol; 1992; 16(8-9):656-60. PubMed ID: 1426820
[TBL] [Abstract][Full Text] [Related]
7. Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease.
Roggenbuck D; Hausdorf G; Martinez-Gamboa L; Reinhold D; Büttner T; Jungblut PR; Porstmann T; Laass MW; Henker J; Büning C; Feist E; Conrad K
Gut; 2009 Dec; 58(12):1620-8. PubMed ID: 19549613
[TBL] [Abstract][Full Text] [Related]
8. [Serodiagnosis of Crohn's disease].
Auer IO; Wensinck F; Röder A; Merwe JP; Schmidt H; Schuster S
Dtsch Med Wochenschr; 1983 Aug; 108(33):1242-6. PubMed ID: 6872878
[TBL] [Abstract][Full Text] [Related]
9. [Immunologic methods in diagnosis of inflammatory bowel disease].
Macura-Biegun A; Błaut A
Przegl Lek; 2002; 59(6):468-71. PubMed ID: 12418289
[TBL] [Abstract][Full Text] [Related]
10. Low prevalence of anti-neutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission.
Lindgren S; Florén CH; Lindhagen T; Starck M; Stewenius J; Nässberger L
Eur J Gastroenterol Hepatol; 1995 Jun; 7(6):563-8. PubMed ID: 7552641
[TBL] [Abstract][Full Text] [Related]
11. Cellular hypersensitivity in ulcerative colitis and Crohn's disease.
Bendixen G
Schweiz Med Wochenschr; 1971 May; 101(20):698-701. PubMed ID: 5578396
[No Abstract] [Full Text] [Related]
12. Anti-neutrophil cytoplasmic antibodies in Brazilian patients with inflammatory bowel disease.
Cabral VL; Miszputen SJ; Catapani WR
Hepatogastroenterology; 2003; 50(50):412-5. PubMed ID: 12749235
[TBL] [Abstract][Full Text] [Related]
13. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
[TBL] [Abstract][Full Text] [Related]
14. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease.
Dotan I; Fishman S; Dgani Y; Schwartz M; Karban A; Lerner A; Weishauss O; Spector L; Shtevi A; Altstock RT; Dotan N; Halpern Z
Gastroenterology; 2006 Aug; 131(2):366-78. PubMed ID: 16890590
[TBL] [Abstract][Full Text] [Related]
15. Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease. Prevalence and diagnostic role.
Kull K; Salupere R; Uibo R; Ots M; Salupere V
Hepatogastroenterology; 1998; 45(24):2132-7. PubMed ID: 9951879
[TBL] [Abstract][Full Text] [Related]
16. Autoimmunity to pancreatic juice in Crohn's disease. Results of an autoantibody screening in patients with chronic inflammatory bowel disease.
Stöcker W; Otte M; Ulrich S; Normann D; Finkbeiner H; Stöcker K; Jantschek G; Scriba PC
Scand J Gastroenterol Suppl; 1987; 139():41-52. PubMed ID: 3324299
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value, clinical utility and pathogenic significance of reactivity to the molecular targets of Crohn's disease specific-pancreatic autoantibodies.
Bogdanos DP; Rigopoulou EI; Smyk DS; Roggenbuck D; Reinhold D; Forbes A; Laass MW; Conrad K
Autoimmun Rev; 2011 Dec; 11(2):143-8. PubMed ID: 21983481
[TBL] [Abstract][Full Text] [Related]
18. Proceedings: A study by immunofluorescence of the intestinal mucosa in ulcerative colitis and Crohn's disease.
Green FH; Fox H
J Med Microbiol; 1973 Nov; 6(4):P18. PubMed ID: 4587399
[No Abstract] [Full Text] [Related]
19. Alterations in serum anti-alpha-galactosyl antibodies in patients with Crohn's disease and ulcerative colitis.
D'Alessandro M; Mariani P; Lomanto D; Bachetoni A; Speranza V
Clin Immunol; 2002 Apr; 103(1):63-8. PubMed ID: 11987986
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type (IBDU).
Mehdizadeh S; Chen G; Enayati PJ; Cheng DW; Han NJ; Shaye OA; Ippoliti A; Vasiliauskas EA; Lo SK; Papadakis KA
Endoscopy; 2008 Jan; 40(1):30-5. PubMed ID: 18058654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]